These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 2030671)

  • 1. Lyme borreliosis: host responses to Borrelia burgdorferi.
    Szczepanski A; Benach JL
    Microbiol Rev; 1991 Mar; 55(1):21-34. PubMed ID: 2030671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology and pathogenesis of Lyme borreliosis].
    Pokorni D; Lako B
    Glas Srp Akad Nauka Med; 1993; (43):123-32. PubMed ID: 8262397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme borreliosis: non-specific interactions of the organism with the host.
    Benach JL; Fernandez Villar B; Szczepanski A; Garcia Monco J
    Scand J Infect Dis Suppl; 1991; 77():130-5. PubMed ID: 1947801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease.
    Cadavid D; O'Neill T; Schaefer H; Pachner AR
    Lab Invest; 2000 Jul; 80(7):1043-54. PubMed ID: 10908149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
    Montgomery RR; Malawista SE; Feen KJ; Bockenstedt LK
    J Exp Med; 1996 Jan; 183(1):261-9. PubMed ID: 8551229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
    Jacquet M; Durand J; Rais O; Voordouw MJ
    Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and sensitizing antibodies in Lyme borreliosis. A microbial adherence immobilization assay for Borrelia burgdorferi (MAIA-BB).
    Cacciapuoti B; Ciceroni L; Fontana L; Perricone R
    Zentralbl Bakteriol; 1993 Feb; 278(1):102-11. PubMed ID: 8518505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM
    APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic aspects of Lyme borreliosis.
    Dattwyler RJ; Volkman DJ; Luft BJ
    Rev Infect Dis; 1989; 11 Suppl 6():S1494-8. PubMed ID: 2682961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete.
    Schwan TG; Simpson WJ
    Scand J Infect Dis Suppl; 1991; 77():94-101. PubMed ID: 1947819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
    Krause A; Burmester GR; Rensing A; Schoerner C; Schaible UE; Simon MM; Herzer P; Kramer MD; Wallich R
    J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.
    Kramer MD; Wallich R; Simon MM
    Infection; 1996; 24(2):190-4. PubMed ID: 8740121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.
    Poljak A; Comstedt P; Hanner M; Schüler W; Meinke A; Wizel B; Lundberg U
    Vaccine; 2012 Jun; 30(29):4398-406. PubMed ID: 22100635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to the three genomic groups of Borrelia burgdorferi in European Lyme borreliosis.
    Dressler F; Ackermann R; Steere AC
    J Infect Dis; 1994 Feb; 169(2):313-8. PubMed ID: 8106763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional
    Batool M; Hillhouse AE; Ionov Y; Kochan KJ; Mohebbi F; Stoica G; Threadgill DW; Zelikovsky A; Waghela SD; Wiener DJ; Rogovskyy AS
    Infect Immun; 2019 Jul; 87(7):. PubMed ID: 30988058
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance.
    Güner ES
    Experientia; 1996 Apr; 52(4):364-72. PubMed ID: 8620942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response in white-footed mice (Peromyscus leucopus) experimentally infected with the Lyme disease spirochete (Borrelia burgdorferi).
    Schwan TG; Kime KK; Schrumpf ME; Coe JE; Simpson WJ
    Infect Immun; 1989 Nov; 57(11):3445-51. PubMed ID: 2807530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk for and patients with Lyme disease.
    Bunikis J; Olsén B; Westman G; Bergstroöm S
    J Clin Microbiol; 1995 Jun; 33(6):1473-8. PubMed ID: 7650170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune evasion by tickborne and host-adapted Borrelia burgdorferi.
    de Silva AM; Fikrig E; Hodzic E; Kantor FS; Telford SR; Barthold SW
    J Infect Dis; 1998 Feb; 177(2):395-400. PubMed ID: 9466527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.